Pharma Blog

Global Product Development | Key Steps and Common Mistakes

Global Product Development | Key Steps and Common Mistakes

1. Product Identification & Target Market Definition Steps: Common Mistakes: 2. API and Excipient Selection Steps: Common Mistakes: 3. Formulation Development Steps: Common Mistakes: 4. Analytical Development Steps: Common Mistakes: 5. Stability and Compatibility Studies Steps: Common Mistakes: 6. Process Optimization and Scale-Up Steps: Common Mistakes: 7. Bioequivalence and Clinical ... Read More
Multiple Peak Plasma Concentrations (Cmax) of Drugs

Multiple Peak Plasma Concentrations (Cmax) of Drugs

There are several potential reasons for multiple peak plasma concentrations. One of which is gut-liver (enterohepatic) recycling (EHR) of drugs. Why is this EHR important for our health? It explains why our gut health (i.e. gut bacteria) can affect drug handling in our body and its treatment (therapeutic) effect. Read ... Read More
Oral Medication with Food versus When Fasted

Oral Medication with Food versus When Fasted

Do we know there is a difference when we take medication orally with food versus when fasted? In a field known as pharmacokinetics, we measure the drug levels in blood with time. When we take medication orally, the blood drug concentration will increase to a maximum value (Cmax) at a ... Read More
Cleaning Validation | FDA vs EMA

Cleaning Validation | FDA vs EMA

I have reviewed 50+ cleaning validation protocols this year. And here is what still surprises me: Most companies treat FDA and EMA requirements as identical twins. They are not. The reality is: Last year, a client passed their FDA pre-approval inspection comfortably. Same facility. Same equipment. Same cleaning procedures. Three ... Read More
Differential Binding of Drug to Plasma Proteins and Tissue Proteins

Differential Binding of Drug to Plasma Proteins and Tissue Proteins

Do we know that substances in blood are being transported around our body by vehicles known as ‘plasma proteins’? In a field known as pharmacokinetics, scientists study how the differential binding of drug to plasma proteins and tissue proteins defines how extensively the drug is being distributed to the bodily ... Read More
Why Vape Laced with Etomidate is Dangerous?

Why Vape Laced with Etomidate is Dangerous?

In brain, etomidate binds to and activate gamma-alpha butyric acid (GABA) receptor. This causes amnesia (forgetfulness), ataxia (unstable movement) and confusion. It further affects ‘wiring’ of a small part of the brain (hippocampus) and may retard brain development of young vapers. It also suppresses hormone and affects kidney and lung ... Read More
Alfentanil Interaction with Rifampin

Alfentanil Interaction with Rifampin

Alfentanil is a potent, short-acting analgesic drug used for anesthesia in surgery. When alfentanil is administered to patients who were pre-treated with rifampin, an anti-tuberculosis drug, its level in our body (i.e. systemic exposure), was reduced 2- to 3-fold! A question arises: What are the rationales behind this interaction? Another ... Read More
Factors Affecting on Clearance of Apixaban

Factors Affecting on Clearance of Apixaban

As we develop drugs to be more stable in our body (i.e. less prone to be broken down by liver), guess what is another route that the drugs are being eliminated from our body? It is intestinal excretion of drugs from the blood circulation to the intestinal lumen and out ... Read More
Removal of Drugs from Kidneys

Removal of Drugs from Kidneys

There are three processes that contribute to the removal of drugs in our kidneys. A question arises: How can we easily predict the relative contributions of these 3 processes? Simple solution: Compare renal clearance (CLR) and filtration clearance (CLf)! We may further ask: how do we calculate CLR and CLf? ... Read More
Why is Testing into Compliance Prohibited?

Why is Testing into Compliance Prohibited?

“Testing into Compliance” — A Red Flag for FDA Inspectors In pharmaceutical manufacturing, data integrity is non-negotiable. Yet some companies still engage in the risky practice of testing into compliance — retesting until a passing result is found, while ignoring or discarding out-of-specification (OOS) results without proper scientific justification. This ... Read More
FDA Guidance: Computer Software Assurance

FDA Guidance: Computer Software Assurance

FDA just released: Computer Software Assurance for Production and Quality System Software FOREWORD What’s new in CSA? The guidance introduces a paradigm shift: Key applications: CSA vs CSV – What’s the advantage? This means more time for innovation, less time buried in paperwork, and better assurance where it counts. CSA ... Read More